| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |